- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07650916
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents With HIV Who Are Virologically Suppressed on ART
This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studiecontact
- Naam: US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
Studie Contact Back-up
- Naam: EU GSK Clinical Trials Call Center
- Telefoonnummer: +44 (0) 20 89904466
- E-mail: GSKClinicalSupportHD@gsk.com
Studie Locaties
-
-
-
Buenos Aires, Argentinië, C1181ACH
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Marisa Sanchez
-
Buenos Aires, Argentinië, C1425AGC
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Sebastian Nunez
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Buenos Aires, Argentinië, C1023AAB
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Veronica Lacal Ridilenir
-
Buenos Aires, Argentinië, 1427
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Pedro Cahn
-
Ciudad Autonoma Buenos Aires, Argentinië, C1405CKC
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Ezequiel Cordova
-
Ciudad Autonoma Buenos Aires, Argentinië, C1425AWK
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Gustavo Lopardo
-
Córdoba, Argentinië, X5000JJS
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Marcelo Martins
-
Rosario, Argentinië, 2000
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Sergio Lupo
-
San Miguel de Tucumán, Argentinië, T4000IHE
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Juan Gonzalo Tomas
-
-
-
-
New South Wales
-
Darlinghurst, New South Wales, Australië, 2010
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Mark O'Reilly
-
Sydney, New South Wales, Australië, 2010
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Mark Bloch
-
-
Queensland
-
Taringa, Queensland, Australië, 4068
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Fiona Bisshop
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
-
Western Australia
-
Perth, Western Australia, Australië, 6000
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Mina John
-
-
-
-
-
Curitiba, Brazilië, 80060-900
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Monica Maria Gomes da Silva
-
Nova Iguaçu, Brazilië, 26030-380
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Aline Ramalho
-
Rio de Janeiro, Brazilië, 21045900
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Beatriz Gilda Grinsztejn
-
Salvador, Brazilië, 40110-060
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Carlos Roberto Alves
-
São Paulo, Brazilië, 04121-000
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Jose Valdez Madruga
-
São Paulo, Brazilië, 04037-030
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- ricardo diaz
-
-
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2T1
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Malcolm Hedgcock
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y 4E9
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Jonathan Angel
-
Toronto, Ontario, Canada, M5G 1K2
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Mona Loutfy
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Alexandra de Pokomandy
-
Montreal, Quebec, Canada, H2L 4E9
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Elise Sasseville
-
Montreal, Quebec, Canada, H2L 4P9
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Jason Szabo
-
Québec, Quebec, Canada, G1R 2J6
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Marie-Louise Vachon
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4P 0W5
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Alexander Wong
-
-
-
-
-
Aichi, Japan, 460-0001
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Yoshiyuki Yokomaku
-
Kanagawa, Japan, 221-0855
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Yukihiro Yoshimura
-
Osaka, Japan, 540-0006
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Dai Watanabe
-
Tokyo, Japan, 162-8655
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Hiroyuki Gatanaga
-
Tokyo, Japan, 108-8639
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Eisuke Adachi
-
Tokyo, Japan, 113-8677
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Ryoko Sekiya
-
-
-
-
-
Guadajalara, Mexico, 44280
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Luz Alicia Gonzalez-Hernandez
-
Mexico City, Mexico, 06760
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Edgar Perez-Barragan
-
Mexico City, Mexico, 14080
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Alvaro Lopez Iñiguez
-
Mérida, Mexico, 97070
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Orlando Paredes Ceballos
-
-
Nuevo León
-
San Pedro Garza García, Nuevo León, Mexico, 66260
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Reynaldo Lara-Medrano
-
-
-
-
-
San Juan, Puerto Rico, 00909
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Javier Morales-Ramirez
-
-
-
-
-
Alicante, Spanje, 03010
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Sergio Reus Bañuls
-
Badalona, Spanje, 08005
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Anna Bonjoch Badia
-
Barcelona, Spanje, 08035
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Joaquin Burgos Cibrian
-
Barcelona, Spanje, 08036
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Josep Mallolas Masferrer
-
Barcelona, Spanje, 08026
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Paula Prieto
-
Barcelona, Spanje, 8907
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Arkaitz Imaz Vacas
-
Burgos, Spanje, 09006
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Luis Buzon
-
Cartagena Murcia, Spanje, 30202
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Francisco Jesús Vera Méndez
-
Córdoba, Spanje, 14004
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Ignacio Pérez Valero
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Elche Alicante, Spanje, 03203
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- MAR MASIA
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Madrid, Spanje, 28031
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Guillermo Cuevas Tascon
-
Madrid, Spanje, 28046
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Maria Luisa Montes Ramirez
-
Madrid, Spanje, 28034
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Sergio Serrano Villar
-
Madrid, Spanje, 28040
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Vicente Estrada
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Madrid, Spanje, 28041
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Rafael Rubio
-
Madrid, Spanje, 28007
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Cristina Diez Romero
-
Sabadell Barcelona, Spanje, 08208
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Marta Navarro Vilasaró
-
Seville, Spanje, Sevilla
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Juan Macias
-
Valencia, Spanje, 46014
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Miguel García Deltoro
-
Vigo Pontevedra, Spanje, 36312
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Antonio Ocampo Hermidia
-
-
Madrid
-
Pozuelo de Alarcón, Madrid, Spanje, 28224
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Alberto Díaz de Santiago
-
-
-
-
-
Liverpool, Verenigd Koninkrijk, L7 8YE
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Emily Clarke
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
London, Verenigd Koninkrijk, W2 1NY
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Caroline Foster
-
London, Verenigd Koninkrijk, WC1E 6JB
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Sarah Pett
-
London, Verenigd Koninkrijk, SE1 7EH
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Julie Fox
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
London, Verenigd Koninkrijk, SW10 9NH
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Ruth Byrne
-
London, Verenigd Koninkrijk, E1 1FR
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Chloe Orkin
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
-
West Midlands
-
Birmingham, West Midlands, Verenigd Koninkrijk, B9 5SS
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Steve Taylor
-
-
-
-
Arizona
-
Phoenix, Arizona, Verenigde Staten, 85015
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Douglas Cunningham
-
-
California
-
Bakersfield, California, Verenigde Staten, 93309
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Franco Felizarta
-
Los Angeles, California, Verenigde Staten, 90027
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- William Towner
-
Los Angeles, California, Verenigde Staten, 90036
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Peter Ruane
-
San Diego, California, Verenigde Staten, 92103
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Timothy Wilkin
-
West Hollywood, California, Verenigde Staten, 90046
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- William Hardy
-
-
Connecticut
-
New Haven, Connecticut, Verenigde Staten, 06510
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Onyema Ogbuagu
-
-
District of Columbia
-
Washington D.C., District of Columbia, Verenigde Staten, 20017
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Theo Hodge
-
-
Florida
-
DeLand, Florida, Verenigde Staten, 32720
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Godson Oguchi
-
Fort Lauderdale, Florida, Verenigde Staten, 33316
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Michael Sension
-
Ft. Pierce, Florida, Verenigde Staten, 34982-7148
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Moti Ramgopal
-
Jacksonville, Florida, Verenigde Staten, 32209
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Mobeen Rathore
-
Miami, Florida, Verenigde Staten, 33136
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Charles Mitchell
-
Orlando, Florida, Verenigde Staten, 32803-1851
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Charlotte-Paige Rolle
-
Pensacola, Florida, Verenigde Staten, 32503
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Mitchell Whitehead
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Vero Beach, Florida, Verenigde Staten, 32960-6541
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Gerald Pierone
-
West Palm Beach, Florida, Verenigde Staten, 33409
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Hector Bolivar
-
West Palm Beach, Florida, Verenigde Staten, 33407
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Olayemi Osiyemi
-
-
Georgia
-
Decatur, Georgia, Verenigde Staten, 30033
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Alexandra Dretler
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60612
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Mariam Aziz
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21287
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Allison Agwu
-
-
Michigan
-
Grosse Pointe Woods, Michigan, Verenigde Staten, 48236
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Leonard Johnson
-
-
Missouri
-
Kansas City, Missouri, Verenigde Staten, 64111
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Blair Thedinger
-
-
Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89101
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Jerry Cade
-
-
New Jersey
-
Newark, New Jersey, Verenigde Staten, 07102-1909
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Jihad Slim
-
-
New Mexico
-
Santa Fe, New Mexico, Verenigde Staten, 87505-4753
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Joel Gallant
-
-
New York
-
Stony Brook, New York, Verenigde Staten, 11794
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Sharon Nachman
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Syracuse, New York, Verenigde Staten, 13057
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Elizabeth Asiago-Reddy
-
-
North Carolina
-
Greensboro, North Carolina, Verenigde Staten, 27401
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Cornelius Van Dam
-
Winston-Salem, North Carolina, Verenigde Staten, 27157
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Caryn Morse
-
-
Ohio
-
Columbus, Ohio, Verenigde Staten, 43210
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Jose Bazan
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- William Short
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15212
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Chiu-Bin Hsiao
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15213-3403
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Sharon Riddler
-
-
Tennessee
-
Memphis, Tennessee, Verenigde Staten, 38105-3678
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Aditya Gaur
-
-
Texas
-
Austin, Texas, Verenigde Staten, 78705-3326
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Cynthia Brinson
-
Dallas, Texas, Verenigde Staten, 75246-2004
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Christopher Bettacchi
-
Dallas, Texas, Verenigde Staten, 75219-4308
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Marc Tribble
-
El Paso, Texas, Verenigde Staten, 79902
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Ogechika Alozie
-
Houston, Texas, Verenigde Staten, 77098
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Gordon Crofoot, Jr., MD
-
-
Utah
-
Salt Lake City, Utah, Verenigde Staten, 84102
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Harry Rosado-Santos
-
-
Virginia
-
Lynchburg, Virginia, Verenigde Staten, 24501
- Werving
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Joseph Saabiye
-
-
Washington
-
Seattle, Washington, Verenigde Staten, 98104
- Werving
- GSK Investigational Site
-
Hoofdonderzoeker:
- Peter Shalit
-
Contact:
- US GSK Clinical Trials Call Center
- Telefoonnummer: 877-379-3718
- E-mail: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Telefoonnummer: +44 (0) 20 8990 4466
- E-mail: GSKClinicalSupportHD@gsk.com
-
Hoofdonderzoeker:
- Audrey Li
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion criteria:
Patient Study Participant (PSP) Inclusion criteria
- Adults and adolescents with HIV-1 infection aged 12 years or older with a weight >35 kg.
- Documented HIV-1 RNA measurements <50 copies/mL in the 12 months prior to Screening.
- HIV-1 RNA <50 copies/mL at screening assessment.
- Must be on current daily oral antiretroviral regimen for at least 6 months uninterrupted prior to Screening.
- Any prior switch in therapy must have occurred due to tolerability/safety, access to medications, or convenience/simplification, and must NOT have been done for virologic treatment failure (HIV-1 RNA ≥200 copies/mL).
Exclusion criteria:
Patient Study Participant (PSP) Exclusion criteria
- Any evidence of primary resistance based on the presence of any major known INSTI (including CAB) or NNRTI (including RPV) resistance-associated mutation
- Treatment with an HIV-1 immunotherapeutic vaccine within 90 days of screening
- Any history of receiving long-acting therapy for treatment or prevention of HIV
- Previous exposure to injectable CAB and/or injectable RPV for treatment or prevention of HIV-1 infection
- Significant uncontrolled or clinically relevant comorbidities (e.g., cardiovascular, hepatic, renal, neurological, psychiatric) that may impact safety or study participation
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: CAB ULA+ RPV ULA
Participants will receive CAB ULA+RPV ULA. |
CAB ULA will be administered. RPV ULA will be administered. |
|
Actieve vergelijker: CAB LA+ RPV LA
Participants will receive CAB LA+RPV LA. |
CAB LA will be administered. RPV LA will be administered. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Percentage of participants with plasma HIV-RNA greater than or equal to (>=) 50 copies (c)/mL as per Food and Drug Administration (FDA) Snapshot algorithm
Tijdsspanne: At Month 11
|
At Month 11
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Percentage of participants with plasma HIV-RNA >= 50 c/mL as per FDA Snapshot algorithm
Tijdsspanne: At Month 23
|
At Month 23
|
|
|
Percentage of participants with plasma HIV-RNA less than (<) 50 c/mL as per FDA Snapshot algorithm
Tijdsspanne: At Month 11 and Month 23
|
At Month 11 and Month 23
|
|
|
Number of participants with treatment emergent genotypic or phenotypic resistance to CAB and RPV
Tijdsspanne: Up to Month 23
|
Up to Month 23
|
|
|
Percentage of participants with confirmed virologic failure (CVF)
Tijdsspanne: Up to Month 11 and Month 23
|
CVF is defined as 2 consecutive HIV-1 RNA levels >=200 c/mL. |
Up to Month 11 and Month 23
|
|
Number of participants with drug-related adverse events (AEs) as per severity of Grade 2-5
Tijdsspanne: Up to Month 11 and Month 23
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of a study intervention, whether or not considered related to the study intervention. Severity is graded according to the Division of Acquired Immunodeficiency Syndrome (DAIDS) grading criteria, where Grade 2 = moderate, Grade 3 = severe, Grade 4 = potentially life-threatening, Grade 5 = death. |
Up to Month 11 and Month 23
|
|
Number of participants with drug-related serious adverse events (SAEs)
Tijdsspanne: Up to Month 11 and Month 23
|
An SAE is defined as any untoward medical occurrence that results in death, is life threatening, requires hospitalization or prolongs existing hospitalization, results in disability/incapacity or other medically significant events. |
Up to Month 11 and Month 23
|
|
Number of participants who discontinue treatment due to AEs or injection intolerability
Tijdsspanne: Up to Month 11 and Month 23
|
Up to Month 11 and Month 23
|
|
|
Plasma concentrations of CAB and RPV
Tijdsspanne: Up to Month 23
|
Up to Month 23
|
|
|
Percentage of adolescent participants with plasma HIV-RNA >= 50 c/mL as per FDA Snapshot algorithm
Tijdsspanne: At Month 11 and Month 23
|
At Month 11 and Month 23
|
|
|
Percentage of adolescent participants with plasma HIV-RNA < 50 c/mL as per FDA Snapshot algorithm
Tijdsspanne: At Month 11 and Month 23
|
At Month 11 and Month 23
|
|
|
Percentage of adolescent participants with confirmed virologic failure (CVF)
Tijdsspanne: Up to Month 11 and Month 23
|
CVF is defined as 2 consecutive HIV-1 RNA levels >=200 c/mL. |
Up to Month 11 and Month 23
|
|
Absolute value of Cluster of Differentiation 4 (CD4+) cell counts in adolescent participants
Tijdsspanne: Up to Month 11 and Month 23
|
Up to Month 11 and Month 23
|
|
|
Change from Baseline in CD4+ cell counts in adolescent participants
Tijdsspanne: At Month 11 and Month 23 compared to baseline (Day 1)
|
At Month 11 and Month 23 compared to baseline (Day 1)
|
|
|
Number of adolescent participants with drug-related AEs as per severity of Grade 2-5
Tijdsspanne: Up to Month 11 and Month 23
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of a study intervention, whether or not considered related to the study intervention. Severity is graded according to the Division of Acquired Immunodeficiency Syndrome (DAIDS) grading criteria, where Grade 2 = moderate, Grade 3 = severe, Grade 4 = potentially life-threatening, Grade 5 = death. |
Up to Month 11 and Month 23
|
|
Number of adolescent participants with drug-related SAEs
Tijdsspanne: Up to Month 11 and Month 23
|
An SAE is defined as any untoward medical occurrence that results in death, is life threatening, requires hospitalization or prolongs existing hospitalization, results in disability/incapacity or other medically significant events. |
Up to Month 11 and Month 23
|
|
Number of adolescent participants who discontinue treatment due to AEs or injection intolerability
Tijdsspanne: Up to Month 11 and Month 23
|
Up to Month 11 and Month 23
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 222794
- 2024-518511-19-00 (Register-ID: CTIS (EU))
- NCT07650916 (Register-ID: ClinicalTrials.gov)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Study Sponsor will assess requests from qualified researchers for anonymized individual patient-level data and related study documents. Data sharing is subject to certain criteria, conditions, and exceptions. For further information, refer to https://www.viiv-studyregister.com/documents/About_ViiV_Patient_Level_Data_Sharing_Final_28May2026.pdf
IPD-tijdsbestek voor delen
Anonymized IPD will be made available within 6 months of publication of primary, key secondary and safety results for studies in product with approved indication(s) or asset(s) with development terminated across all indications.
IPD-toegangscriteria voor delen
Anonymized IPD is shared with researchers whose proposals are approved by an Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension may be granted, when justified, for up to 6 months.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
- MVO
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .